Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage I Adult Liver Cancer”

313 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 313 results

Testing effectiveness (Phase 2)Study completedNCT01271504
What this trial is testing

E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Eisai Inc. 102
Testing effectiveness (Phase 2)Active Not RecruitingNCT06239155
What this trial is testing

A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsHepatocellular Carcinoma
Ascentawits Pharmaceuticals, Ltd 51
Early research (Phase 1)Ended earlyNCT01668017
What this trial is testing

A Multicentre, Open Label, Phase 1 Trial in Japan of the Mitogen Activated Protein Extracellular Signal Regulated Kinase (MEK) Inhibitor Pimasertib Given Orally to Subjects With Solid Tumors as Monotherapy

Who this might be right for
Advanced Solid TumorsHepatocellular Carcinoma
Merck KGaA, Darmstadt, Germany 26
Early research (Phase 1)Looking for participantsNCT06066138
What this trial is testing

Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Who this might be right for
Locally Advanced Alveolar Soft Part SarcomaMetastatic Alveolar Soft Part SarcomaLocally Advanced Non Small Cell Lung Cancer+7 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT01004003
What this trial is testing

Phase I/II Comparison of Efficacy and Safety of BIBF 1120 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Boehringer Ingelheim 125
Early research (Phase 1)Ended earlyNCT05352542
What this trial is testing

GPC3-targeting CART Cell in Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
jianming xu 10
Testing effectiveness (Phase 2)Ended earlyNCT04212221
What this trial is testing

MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Zai Lab (Shanghai) Co., Ltd. 89
Testing effectiveness (Phase 2)Study completedNCT00784290
What this trial is testing

Phase I/II Study of TSU-68 for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Taiho Pharmaceutical Co., Ltd. 35
Large-scale testing (Phase 3)Ended earlyNCT02504099
What this trial is testing

Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular Carcinoma

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 3
Early research (Phase 1)Temporarily pausedNCT06217094
What this trial is testing

Study of NP-101 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Undergoing Y-90 Treatment

Who this might be right for
Hepatocellular Carcinoma
University of Florida 18
Early research (Phase 1)Ended earlyNCT01942083
What this trial is testing

A Phase I, Open Label, Non Randomized, Multicenter, Dose Escalation Clinical Study to Investigate Safety and Tolerability of OPB(Otsuka Pharmaceutical Biwa)-111077 in Subjects With Advanced HCC(Hepatocellular Carcinoma)

Who this might be right for
Advanced Hepatocellular Carcinoma
Korea Otsuka Pharmaceutical Co., Ltd. 33
Early research (Phase 1)Looking for participantsNCT07369505
What this trial is testing

Sapu003 in Advanced mTOR-sensitive Solid Tumors

Who this might be right for
Breast Cancer MetastaticRenal Cell Carcinoma (RCC)Neuroendocrine Tumors+2 more
SAPU NANO (US) LLC 27
Testing effectiveness (Phase 2)Ended earlyNCT03071094
What this trial is testing

A Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma (HCC)
Transgene 14
Early research (Phase 1)Study completedNCT00486356
What this trial is testing

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
University of Nebraska 46
Early research (Phase 1)Active Not RecruitingNCT02772003
What this trial is testing

DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic HepatitisHepatitis C InfectionHepatocellular Carcinoma
National Cancer Institute (NCI) 33
Testing effectiveness (Phase 2)Looking for participantsNCT03539822
What this trial is testing

Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies

Who this might be right for
Gastric CancerEsophageal AdenocarcinomaHepatocellular Carcinoma+1 more
Anwaar Saeed 117
Early research (Phase 1)UnknownNCT04973098
What this trial is testing

Phase I Clinical Trial of CT0181 Cells in the Treatment of Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Peking University 13
Early research (Phase 1)Ended earlyNCT00562666
What this trial is testing

Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells

Who this might be right for
Hepatocellular Carcinoma
Rennes University Hospital 2
Not applicableUnknownNCT05621499
What this trial is testing

HAIC or Lenvatinib Combined With Sintilimab for High Recurrence Risk Resectable Solitary Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03107416
What this trial is testing

Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells

Who this might be right for
Unresectable Hepatocellular Carcinoma
Memorial Sloan Kettering Cancer Center 30
Load More Results